1
/
of
0
FDA FAERS Reports on IZERVAY (avacincaptad pegol) – Jan 1, 2024 to Mar 3, 2035
FDA FAERS Reports on IZERVAY (avacincaptad pegol) – Jan 1, 2024 to Mar 3, 2035
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: FDA FAERS reports on the drug IZERVAY (avacincaptad pegol), from 1/1/24 to 3/3/35. Please look for events under both the brand and generic names. Where possible, please include full narrative of events, and email the results in a PDF or Excel file.
Tags: Pharma, FAERS, 2025
Tags: Pharma, FAERS, 2025
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details